Related Experiment Videos
Telomerase activity in normal and neoplastic breast
1Department of Pathology, University of Southern California School of Medicine, Los Angeles, California 90033, USA.
Summary
Telomerase activation is common in human breast cancers, including early stages like ductal carcinoma in situ. This enzyme
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Telomeres shorten with each cell division, limiting proliferation.
- Telomerase counteracts telomere shortening, enabling cancer cell immortality.
- Telomerase activity is a hallmark of many human cancers.
Purpose of the Study:
- To investigate telomerase activity in human breast cancer specimens.
- To determine correlations between telomerase activity and clinicopathological features.
- To assess the role of telomerase in early breast cancer progression.
Main Methods:
- Modified telomeric repeat amplification protocol (TRAP) assay.
- Analysis of 49 human breast cancer specimens, including ductal carcinoma in situ and invasive tumors.
- Microdissection of tumor regions to assess telomerase expression heterogeneity.
Main Results:
- Telomerase activity detected in 76% of breast cancer specimens.
- High prevalence of telomerase activity in ductal carcinoma in situ (75%).
- No correlation found between telomerase activity and tumor stage or hormone receptor status.
- Heterogeneous telomerase expression observed in some invasive tumors.
- Low telomerase activity detected in 17% of non-cancerous breast specimens.
Conclusions:
- Telomerase activation appears to be an early event in breast cancer development.
- Telomerase activity may be dynamically regulated during tumor progression.
- Telomerase is a potential target for early breast cancer detection and therapy.